Experimental drug targets tough liver cancers in first human trial
NCT ID NCT07164313
Summary
This is the first study in humans testing whether ZW251, a new targeted cancer drug, is safe and can help people with advanced liver cancer and other solid tumors. Researchers will give the drug to about 100 participants to find the right dose and see if it shrinks tumors. The main goals are to check for side effects and see if the treatment shows early signs of working against the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
Contact
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
Contact
-
Kansai Medical University Hospital
RECRUITINGOsaka, 573-1191, Japan
Contact
-
Kyoto University Hospital
RECRUITINGKyoto, 606-8507, Japan
Contact
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
-
NEXT Oncology Madrid
RECRUITINGMadrid, 28223, Spain
Contact
-
National Cancer Center East
RECRUITINGKashiwa, 2778577, Japan
Contact
-
National Cancer Center Hospital
RECRUITINGTokyo, 104-0045, Japan
Contact
-
National Taiwan University Hospital
RECRUITINGTaipei, 100225, Taiwan
Contact
-
Norton Cancer Institute
RECRUITINGLouisville, Kentucky, 40202, United States
Contact
-
START - Dublin Mater Misericordiae University Hospital (MMUH)
RECRUITINGDublin, D07 R2WY, Ireland
Contact
-
START - Rioja Hospital Universitario San Pedro
RECRUITINGLogroño, 26006, Spain
Contact
-
START Barcelona
RECRUITINGBarcelona, 29010, Spain
Contact
-
START Lisboa a - Unidade de Ensaios ClÃnicos - Hospital de Santa Maria
RECRUITINGLisbon, 1649-035, Portugal
Contact
-
START Madrid Hospital Universitario Fundacion Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
Contact
-
START Madrid Hospital Universitario HM Sanchinarro - CIOCC
RECRUITINGMadrid, 28050, Spain
Contact
-
START Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
Contact
-
START San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
-
Taipei Veterans General Hospital
RECRUITINGTaipei, 112201, Taiwan
Contact
-
UCSF Comprehensive Cancer Center
RECRUITINGSan Francisco, California, 94158, United States
Contact
Conditions
Explore the condition pages connected to this study.